Hong-Xin Deng Selected Research

Hong-Xin Deng Research Topics

Disease

21	Neoplasms (Cancer) 01/2017 - 02/2003
4	Carcinoma (Carcinomatosis) 08/2010 - 01/2009
3	Hepatocellular Carcinoma (Hepatoma) 07/2011 - 03/2006
3	Lung Neoplasms (Lung Cancer) 02/2010 - 10/2004
2	Necrosis 01/2017 - 11/2009
2	Adenocarcinoma of Lung 12/2012 - 10/2004
2	Colonic Neoplasms (Colon Cancer) 08/2012 - 06/2010
2	Neoplasm Metastasis (Metastasis) 02/2010 - 11/2004
2	Lewis Lung Carcinoma 12/2007 - 10/2004
1	Inflammation (Inflammations) 01/2021
1	Schizophrenia (Dementia Praecox) 01/2021
1	Crohn Disease (Crohn's Disease) 01/2017
1	Fistula 01/2017
1	Glioma (Gliomas) 08/2011
1	Colorectal Neoplasms (Colorectal Cancer) 08/2011
1	Psoriasis (Pustulosis Palmaris et Plantaris) 08/2010
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2010
1	Ovarian Neoplasms (Ovarian Cancer) 01/2009
1	Pathologic Neovascularization 06/2008
1	Fibrosarcoma 10/2007
1	Melanoma (Melanoma, Malignant) 03/2006
1	Nasopharyngeal Carcinoma 11/2005
1	Vesicular Stomatitis 10/2004

Drug/Important Bio-Agent (IBA)

6	VaccinesIBA 01/2017 - 02/2003
6	Small Interfering RNA (siRNA)IBA 08/2011 - 01/2009
6	Liposomes (Liposome)IBA 08/2011 - 10/2007
4	Gemcitabine FDA Link 12/2012 - 10/2004
4	Proliferating Cell Nuclear Antigen (PCNA)IBA 08/2011 - 01/2009
4	Proteins (Proteins, Gene)FDA Link 08/2011 - 04/2005
4	AntigensIBA 08/2010 - 07/2004
4	Immunoglobulins (Immunoglobulin)IBA 03/2006 - 02/2003
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 01/2005
3	Focal Adhesion Protein-Tyrosine KinasesIBA 08/2011 - 06/2010
3	AutoantibodiesIBA 03/2006 - 02/2003
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2005
2	AntibodiesIBA 01/2017 - 11/2005
2	Messenger RNA (mRNA)IBA 08/2012 - 08/2011
2	1,2- dioleoyloxy- 3- (trimethylammonium)propaneIBA 08/2011 - 06/2010
2	Antimicrobial PeptidesIBA 11/2009 - 06/2008
2	EndoglinIBA 11/2004 - 07/2004
2	Cisplatin (Platino)FDA LinkGeneric 11/2004 - 01/2004
1	Antipsychotic Agents (Antipsychotics)IBA 01/2021
1	Lipopolysaccharide ReceptorsIBA 01/2021
1	Cancer VaccinesIBA 01/2017
1	MicroRNAs (MicroRNA)IBA 08/2012
1	PropaneIBA 08/2011
1	CholesterolIBA 08/2011
1	Coloring Agents (Dyes)IBA 08/2011
1	Polo-Like Kinase 1IBA 08/2011
1	Therapeutic UsesIBA 07/2011
1	RNA (Ribonucleic Acid)IBA 01/2011
1	MitogensIBA 08/2010
1	DNA (Deoxyribonucleic Acid)IBA 08/2010
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 08/2010
1	Interleukin-4 (Interleukin 4)IBA 08/2010
1	CytokinesIBA 08/2010
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 08/2010
1	Peptides (Polypeptides)IBA 11/2009
1	Interleukin-12 (IL 12)IBA 07/2009
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2009
1	Angiogenesis InhibitorsIBA 06/2008
1	LipofectamineIBA 12/2007
1	Complementary DNA (cDNA)IBA 12/2007
1	dioleoyl-N-(monomethoxypolyethylene glycol succinyl)phosphatidylethanolamineIBA 10/2007
1	phosphatidylethanolamineIBA 10/2007
1	Ethylene Glycol (Monoethylene Glycol)IBA 10/2007
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2006
1	Tumor Biomarkers (Tumor Markers)IBA 11/2005
1	Chemotactic FactorsIBA 04/2005
1	Interferon-gamma (Interferon, gamma)IBA 04/2005
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2005
1	Biological ProductsIBA 01/2005
1	AlginatesIBA 07/2004
1	Combined VaccinesIBA 01/2004
1	GelatinIBA 02/2003
1	Matrix Metalloproteinases (MMPs)IBA 02/2003
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 02/2003
1	GelatinasesIBA 02/2003

Therapy/Procedure

13	Therapeutics 01/2017 - 02/2003
6	Immunotherapy 10/2007 - 01/2004
2	Biological Therapy 08/2010 - 11/2004
2	Drug Therapy (Chemotherapy) 01/2005 - 11/2004
1	Transplantation 01/2017
1	Subcutaneous Injections 08/2010